论文信息 - Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders - 字舞流文

Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders

Juliana K. Wambua | B. Lowe | K. Marsh | B. Ogutu | P. Njuguna | P. Bejon | I. Jao | V. Marsh | S. Kariuki | P. Billingsley | B. Sim | M. Imwong | J. Tarning | D. Kamuya | George Nyangweso | J. Oloo | J. Musyoki | A. Abdi | M. Hamaluba | M. Winterberg | Y. Abebe | J. Ngoi | S. Murphy | S. Kinyanjui | J. Tuju | E. Otieno | Michelle K Muthui | M. Kapulu | D. Mwanga | F. Ndungu | M. Mosobo | J. Makale | P. Chi | F. Osier | M. Njue | J. Mwacharo | D. Omuoyo | Martin Ongas | L. Murungi | Z. D. de Laurent | M. Ooko | T. Williams | Peter Bull | Cheryl A. Kivisi | J. Musembi | Omar Ngoto | R. Kimathi | K. Mohammed | Fredrick Olewe | J. Shangala | E. Owino | John M Ongecha | Domitila Kimani | Susanne H. Hodgson | Joyce Mwongeli | Nelson K Kibinge | Nelly Koskei | Stephen L. Hoffman | Eric R. James | Ag Audi | Gathoni Kamuyu | Abdirahman I. Yonas Agnes Peter Peter C. Mainga Zaydah Susann Abdi Abebe Audi Billingsley Bull Hamal | Agnes Audi | S. Hodgson

[1] M. Selgelid,et al. Human Challenge Studies in Endemic Settings , 2020 .

[2] G. Kang,et al. Human challenge trials in vaccine development , 2020, Seminars in Immunology.

[3] P. Bejon,et al. Deliberately infecting healthy volunteers with malaria parasites: Perceptions and experiences of participants and other stakeholders in a Kenyan‐based malaria infection study , 2020, Bioethics.

[4] M. Roestenberg,et al. Money-oriented risk-takers or deliberate decision-makers: a cross-sectional survey study of participants in controlled human infection trials , 2020, BMJ Open.

[5] M. Selgelid,et al. COVID-19 human challenge studies: ethical issues , 2020, The Lancet Infectious Diseases.

[6] M. Selgelid,et al. Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy , 2020, Journal of Medical Ethics.

[7] I. Boutron,et al. The research burden of randomized controlled trial participation: a systematic thematic synthesis of qualitative evidence , 2020, BMC Medicine.

[8] M. Parker,et al. Stakeholder views on the acceptability of human infection studies in Malawi , 2019, BMC Medical Ethics.

[9] Seema K. Shah,et al. Exploring Ethical Concerns About Human Challenge Studies: A Qualitative Study of Controlled Human Malaria Infection Study Participants’ Motivations and Attitudes , 2018, Journal of empirical research on human research ethics : JERHRE.

[10] Z. Bánkowski. Council for International Organizations of Medical Sciences , 2019, Cobert's Manual of Drug Safety and Pharmacovigilance.

[11] T. Richie,et al. Human challenge trials in vaccine development, Rockville, MD, USA, September 28-30, 2017. , 2019, Biologicals : journal of the International Association of Biological Standardization.

[12] P. Njuguna,et al. Controlled Human Malaria Infection in Semi-Immune Kenyan Adults (CHMI-SIKA): a study protocol to investigate in vivo Plasmodium falciparum malaria parasite growth in the context of pre-existing immunity , 2018, Wellcome open research.

[13] P. Njuguna,et al. Controlled Human Malaria Infection in Semi-Immune Kenyan Adults (CHMI-SIKA): a study protocol to investigate in vivo Plasmodium falciparum malaria parasite growth in the context of pre-existing immunity , 2018, Wellcome open research.

[14] J. Fisher,et al. Healthy Volunteers’ Perceptions of the Benefits of Their Participation in Phase I Clinical Trials , 2018, Journal of empirical research on human research ethics : JERHRE.

[15] B. Mordmüller,et al. Experimental infection of human volunteers. , 2018, The Lancet. Infectious diseases.

[16] Seema K. Shah,et al. Bystander risk, social value, and ethics of human research , 2018, Science.

[17] P. Njuguna,et al. Ethical considerations in Controlled Human Malaria Infection studies in low resource settings: Experiences and perceptions of study participants in a malaria Challenge study in Kenya. , 2018, Wellcome open research.

[18] J. McCarthy,et al. Controlled Human Malaria Infection: Applications, Advances, and Challenges , 2017, Infection and Immunity.

[19] P. Bejon,et al. A framework for Controlled Human Infection Model (CHIM) studies in Malawi: Report of a Wellcome Trust workshop on CHIM in Low Income Countries held in Blantyre, Malawi , 2017, Wellcome open research.

[20] Seema K. Shah,et al. ETHICAL CONSIDERATIONS FOR ZIKA VIRUS HUMAN CHALLENGE TRIALS , 2017 .

[21] J. Ives,et al. Empirical Bioethics: Theoretical and Practical Perspectives , 2017 .

[22] C. Weijer,et al. Ethical Criteria for Human Challenge Studies in Infectious Diseases. , 2016, Public health ethics.

[23] Joanna Różyńska. On the Alleged Right to Participate in High‐Risk Research , 2015, Bioethics.

[24] S. Hoffman,et al. Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya , 2015, Malaria Journal.

[25] Ross J. Anderson,et al. The collection, linking and use of data in biomedical research and health care: ethical issues , 2015 .

[26] S. Hoffman,et al. Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection , 2014, Front. Microbiol..

[27] Davina B Lohm,et al. Interviewing pairs: discussions on migration and identity , 2014 .

[28] N. Gale,et al. Using the framework method for the analysis of qualitative data in multi-disciplinary health research , 2013, BMC Medical Research Methodology.

[29] V. Marsh,et al. ENGAGING COMMUNITIES TO STRENGTHEN RESEARCH ETHICS IN LOW-INCOME SETTINGS: SELECTION AND PERCEPTIONS OF MEMBERS OF A NETWORK OF REPRESENTATIVES IN COASTAL KENYA , 2013, Developing world bioethics.

[30] C. Grady,et al. Developing a Model of the Benefits and Burdens of Research Participation in Cancer Clinical Trials , 2012, AJOB primary research.

[31] D. Wendler,et al. A Framework for Risk-Benefit Evaluations in Biomedical Research , 2011, Kennedy Institute of Ethics journal.

[32] V. Marsh,et al. Beginning community engagement at a busy biomedical research programme: Experiences from the KEMRI CGMRC-Wellcome Trust Research Programme, Kilifi, Kenya , 2008, Social science & medicine.

[33] Ezekiel J Emanuel,et al. What makes clinical research in developing countries ethical? The benchmarks of ethical research. , 2004, The Journal of infectious diseases.

[34] T. Hope,et al. Challenge studies of human volunteers: ethical issues , 2004, Journal of Medical Ethics.

[35] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..

[36] F G Miller,et al. The ethical challenge of infection-inducing challenge experiments. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37] R. Levine. Referral of patients with cancer for participation in randomized clinical trials: Ethical considerations , 1986, CA: a cancer journal for clinicians.

[38] I. Knezevic,et al. [Biological standardization]. , 1972, Harefuah.